About HERMES PHARMA
HERMES PHARMA is a Healthcare company based in Pullach (Germany) founded in 1997. Manufacturer of drug development for clinical studies and logistics supply services. HERMES PHARMA offers products and services including Orally Disintegrating Granules, Chewable Tablets, Effervescent Tablets, Instant Drinks, and Lozenges. Its focus areas include Biopharma Outsourcing, CDMO and Diversified.
Company details
Hermes Pharma was established in 1997 in Pullach, Germany, within the pharmaceutical sector. Drug development processes for clinical studies are handled, alongside logistics and supply chain services. Operations emphasize manufacturing support for trials, including formulation and distribution. The company serves global needs from its European base, focusing on regulatory compliance and efficient delivery in drug research.
- Headquarters Pullach, Germany
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website hermes-pharma.com
- Social LinkedIn YouTube
- Latest Funding Round$298.36K (USD), Grant
Jun 2023
- Investors
Products & Services of HERMES PHARMA
HERMES PHARMA offers a comprehensive portfolio of products and services, including Orally Disintegrating Granules, Chewable Tablets, Effervescent Tablets, Instant Drinks, and Lozenges.
Granules that dissolve in the mouth for easy, on-the-go consumption.
Tablets designed for chewing to improve solubility and user experience.
Tablets that dissolve in water for a pleasant drink with multiple APIs.
Powders that mix into drinks for convenient dosage administration.
Slow-dissolving forms for localized effects in indications like cough relief.
Apps and channels of HERMES PHARMA
its YouTube channel HERMES PHARMA - Get the dose right has 50 subscribers and 4 videos.
Videos from HERMES PHARMA
The most watched videos on HERMES PHARMA's YouTube channel, HERMES PHARMA - Get the dose right (50 subscribers). Click a video to play it here.
More on HERMES PHARMA - Get the dose right.
Funding Insights of HERMES PHARMA
- Total Rounds 1
- Last Round Grant — $298,364
- First Round $298,364
(Jun 2023)
- Investors Count 1
All 1 funding rounds of HERMES PHARMA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2023 | $298,364 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in HERMES PHARMA
HERMES PHARMA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Austria Wirtschaftsservice.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Banking regulatory services are provided for Austrian financial institutions. | 2002 | aws.at | Vienna, Austria |
Investor details for HERMES PHARMA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of HERMES PHARMA
2 dated milestones of HERMES PHARMA across 26 years, from founding to its latest funding, stage changes and deals.
- Founded HERMES PHARMA is founded.
- Funding First funding round of $298K.
Web traffic of HERMES PHARMA
The website of HERMES PHARMA (hermes-pharma.com) receives about 2.9K visits a month and ranks #4,320,845 among all websites worldwide, #5,301 in Biotechnology and Pharmaceuticals.
- Monthly visits2.9K
▼ 26.3% vs previous month
- Unique visitors1.4K
per month
- Global rank#4,320,845
among all websites
- Category rank#5,301
Health · Biotechnology and Pharmaceuticals
- Bounce rate42%
- Pages per visit2.3
- Average visit1 min 46 sec
- DevicesDesktop 58% · Mobile 42%
Websites whose visitors overlap most with HERMES PHARMA. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| syncobiopartners.com | 100% | View details | |||
atrapharma.com | atrapharma.com | 89% | – | ||
ecv.de | ecv.de | 83% | #2,675,407 | – | |
pharmtech.com | pharmtech.com | 83% | #505,753 | – | |
| nutrilo.de | 83% | #8,435,112 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for HERMES PHARMA
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hermes Pharma
Complete news archive for HERMES PHARMA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HERMES PHARMA
HERMES PHARMA was founded in 1997 and raised its 1st funding round 26 years after it was founded.
HERMES PHARMA is headquartered in Pullach, Germany. It is registered at Pullach, Bavaria, Germany.
Hermes Pharma was established in 1997 in Pullach, Germany, within the pharmaceutical sector. Drug development processes for clinical studies are handled, alongside logistics and supply chain services. Operations emphasize manufacturing support for trials, including formulation and distribution. The company serves global needs from its European base, focusing on regulatory compliance and efficient delivery in drug research.
HERMES PHARMA offers Orally Disintegrating Granules, Chewable Tablets, Effervescent Tablets, Instant Drinks, and Lozenges.
HERMES PHARMA has 1 investor. Key investors include Austria Wirtschaftsservice.